On a pedestrianised street in Warrington, a converted vehicle the size of a delivery van has been quietly outperforming the system built to replace it. Women queue outside from mid-morning, some resolute, others visibly anxious, for cervical screening they had put off for years. Inside, purple lighting and a bed replace the strip-lit clinical bustle of a GP surgery. There is no appointment to book, no eight-week wait, no risk of being seen by the practice nurse who also treats your asthma. Since 2024, two such buses have screened more than 2,700 women across Cheshire, Merseyside, Lancashire and South Cumbria, a fifth of whom had never been screened before.

The instinct is to read this as a heartening story about NHS ingenuity. It is that, but it is also a quiet indictment. A converted bus should not be the mechanism by which a health service delivers something GP practices are already commissioned to provide. That it has come to this says less about the imagination of NHS England North West than about the rigidity of the system the bus exists to route around.

England's cervical screening coverage has fallen from roughly 77 per cent to 69 per cent over the past decade, one of the steepest declines among OECD countries. The reasons are mundane rather than mysterious: inflexible appointment slots, a shortage of sample-takers, the discomfort of being examined by someone you know. Women from deprived areas, ethnic minority backgrounds and disabled communities are consistently the least likely to be up to date. None of this is new information. What is newer is the sense that the NHS's answer increasingly lies outside the conventional consultation room altogether, in home HPV self-sampling kits and in buses parked outside Boots.

This puts Yvette Cooper in an odd position. She inherited the Health and Social Care brief from Andy Burnham in July, arriving with a 10-Year Health Plan already drafted around three shifts: hospital to community, analogue to digital, treatment to prevention. Self-sampling kits, now expanding to under-screened groups through 2026 as part of the push toward eliminating cervical cancer by 2040, fit that digital and preventive framing neatly. A mobile clinic with a nurse and a parking permit fits it rather less well. Both are demonstrably effective. Neither is obviously part of the same coherent strategy, and that distinction matters more than it might first appear.

A postal kit scales cheaply once the logistics are built. A bus does not. It needs staff pulled from wards or GP rotas, fuel, insurance, a booking system for the vehicle itself and a business case renewed by whichever regional NHS body still exists to approve it after the reorganisation of NHS England. It is precisely the kind of unglamorous, labour-intensive intervention that survives a launch announcement but struggles to survive a budget round, because its savings in avoided late-stage cancer treatment accrue a decade later and to a different balance sheet than the one currently under strain.

That mismatch between prevention's timescale and the Treasury's is not new to Cooper, but it will define whether her early rhetoric survives contact with Rachel Reeves's successor's autumn spending decisions. Every health secretary since at least Andrew Lansley has pledged to shift resource upstream, and every one has found the downstream pressures of waiting lists and winter capacity too politically urgent to resist. Prevention loses in the annual reckoning because its failures are invisible and its costs are immediate.

What the Warrington bus actually demonstrates is not that mobile clinics are the answer, but that flexibility of access is, and that the NHS currently has to improvise elaborate physical workarounds to provide something as simple as a same-day, no-appointment test. If Cooper wants her tenure to mean something for prevention beyond a slogan carried over from her predecessor, the test will not be whether she funds another pilot scheme. It will be whether ordinary general practice can eventually make the queue outside the bus unnecessary.